Multimorbidity
Revise how multiple conditions interact, how treatment burden changes decisions, and why the safest answer is often person-centred rather than disease-by-disease.
MRCGP AKT long-term conditions and cancer revision
This topic tests everyday GP judgement: chronic disease reviews, multimorbidity, treatment burden, cancer red flags, safety-netting, survivorship and palliative transition.
Quick answer
For AKT long-term conditions and cancer revision, prioritise multimorbidity, treatment burden, chronic disease monitoring, cancer red flags, NICE suspected-cancer referral, safety-netting, survivorship and palliative transitions.
What to revise first
Long-term condition reviews
Know the purpose of structured reviews, monitoring tests, lifestyle support, medicines optimisation, escalation thresholds and shared management plans.
Cancer red flags
Focus on symptom patterns, age thresholds, persistent unexplained symptoms, examination findings and when NICE suspected-cancer pathways apply.
Safety-netting
AKT stems often test whether you arrange follow-up, explain what change should trigger review and make sure abnormal results do not get lost.
Living with and beyond cancer
Cover survivorship, recurrence concerns, late treatment effects, psychological impact, coordination with secondary care and holistic needs.
Palliative transition
Recognise when care shifts toward symptom control, advance care planning, carer support, anticipatory medicines and community coordination.
Red flags to recognise quickly
- Haemoptysis, persistent cough, recurrent chest infections, weight loss or appetite loss in a patient at lung-cancer risk
- Iron-deficiency anaemia, rectal bleeding, change in bowel habit, abdominal mass or unexplained weight loss
- Breast lump, nipple change, skin dimpling, unilateral persistent symptoms or suspicious breast examination finding
- Changing pigmented lesion, non-healing ulcer, rapidly growing lesion or skin lesion with suspicious bleeding or colour change
- Persistent unexplained bone pain, pallor, bruising, lymphadenopathy or soft-tissue lump in a child or young person
- Multimorbidity with rapid functional decline, treatment toxicity, medication harm, frailty, carer breakdown or unsafe self-management
Why this topic catches candidates out
The hard part is choosing the safest next step when several problems compete. AKT questions may give a familiar disease, but the answer turns on cancer risk, medication harm, follow-up reliability, patient goals or whether further treatment creates more burden than benefit.
AKT long-term conditions and cancer FAQ
Is long-term conditions including cancer high yield for the AKT?
Yes. It is a named RCGP curriculum topic and it overlaps with common AKT scenarios: multimorbidity, long-term condition monitoring, cancer red flags, 2WW referral, safety-netting, survivorship and palliative transition.
What should I revise first for this AKT topic?
Start with multimorbidity, treatment burden, shared decisions, structured chronic disease reviews, medicines optimisation, NICE suspected-cancer referral patterns, safety-netting and follow-up systems.
How do cancer red flags come up in AKT questions?
They usually appear as a primary-care presentation where the key decision is investigation, urgent suspected-cancer referral, safety-netting, or recognising that persistent unexplained symptoms should not be treated as benign.
What is the AKT trap with multimorbidity?
The trap is applying a single guideline without considering frailty, renal function, side effects, patient priorities, carers, treatment burden and whether extra investigation or treatment is likely to help.
Official sources
This is revision guidance, not official RCGP advice. Check current RCGP, NICE, local cancer pathways, local long-term condition protocols and BNF guidance for clinical decisions. Last reviewed June 2026.
October sitting
Oct 26
--
days
Keep moving, even on tired days.
Questions, mocks and explanations are free. Your first 2 hours of AKT audio are free. Full 4-month audio access is £79.